Otsuka Holdings Co., Ltd.: all 780 studies

Page 1 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• Nutritional Status in Patients With Chronic Kidney Disease Receiving 7.2% Amino Acids During HemodialysisRecruitingNCT07881627
• Early Access Program for Ulefnersen in Children, Adolescents and Adults With FUS-associated Amyotrophic Lateral Sclerosis (FUS-ALS)AvailableNCT07862959
• A Study to Evaluate the Effectiveness and Safety of Sibeprenlimab in Participants With Primary Membranous Nephropathy, Immune-mediated Focal Segmental Glomerulosclerosis, and Minimal Change DiseaseNot yet recruitingNCT07861113Phase 2
• An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSDRecruitingNCT07836647Phase 3
• A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety DisorderRecruitingNCT07786454Phase 3
• Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)Not yet recruitingNCT07770815Phase 3
• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety DisorderRecruitingNCT07767903Phase 3
• A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional DysregulationRecruitingNCT07759154Phase 3
• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety DisorderRecruitingNCT07759128Phase 3
• A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney FunctionRecruitingNCT07713758Phase 1
• Futibatinib (TAS-120) in Patients With Advanced Biliary Tract CancerRecruitingNCT07710885Phase 3
• A Study of ARC-02 in B-cell NHLRecruitingNCT07691606Phase 1
• An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSDEnrolling by invitationNCT07670702Phase 3
• A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the BodyRecruitingNCT07649265Phase 1
• An EAP Treatment Protocol of ZipalertinibAvailableNCT07601399
• A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the BodyRecruitingNCT07525960Phase 1
• An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)RecruitingNCT07456696Phase 3
• A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male AdultsNot yet recruitingNCT07455084Phase 1
• An Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health ImprovementRecruitingNCT07453693Not applicable
• A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered TogetherRecruitingNCT07446400Phase 1
• JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal WomenRecruitingNCT07238478Not applicable
• The RADIANCE CED StudyRecruitingNCT07231757
• A Long-term Administration Trial of SEP-363856 in Patients With SchizophreniaRecruitingNCT07225712Phase 3
• A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisRecruitingNCT07209761Phase 3
• A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic DermatitisNot yet recruitingNCT07184645Phase 3
• A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic DermatitisNot yet recruitingNCT07173478Phase 3
• A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionRecruitingNCT07128199Phase 3
• A Long-term Trial of EB-1020 in Pediatric Patients With ADHDRecruitingNCT07087327Phase 3
• A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHDRecruitingNCT07086313Phase 2/3
• A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/LymphomaRecruitingNCT07075328Phase 1/2
• LUPKYNIS Drug-use Results SurveyRecruitingNCT07053891
• A Study of JNT-517 in Participants With Phenylketonuria (PKU)RecruitingNCT06971731Phase 3
• Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD PatientsRecruitingNCT06931080Phase 2/3
• A Long-term Trial of EB-1020 in Adult Patients With ADHDRecruitingNCT06926829Phase 3
• REXULTI General Use Results Survey in Patients With Hyperactivity, or Aggressive Behavior Associated With Alzheimer's DementiaRecruitingNCT06875986
• A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General PopulationRecruitingNCT06837246Not applicable
• Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney TissueRecruitingNCT06740526Phase 2
• Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)Not yet recruitingNCT06674291
• A Long-Term Study of JNT-517 in Participants With PhenylketonuriaRecruitingNCT06628128Phase 3
• Effect of a Nutritional Supplement on Gut Microbiota in AdultsNot yet recruitingNCT06611215Not applicable
• A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruitingNCT06575426Phase 1/2
• Global Paradise System US Post Approval StudyRecruitingNCT06297291
• A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.RecruitingNCT05967689Phase 2
• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or RearrangementRecruitingNCT05727176Phase 2
• Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term UseRecruitingNCT05342493
• Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute SchizophreniaRecruitingNCT05325645Phase 3
• Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)Enrolling by invitationNCT05248659Phase 2/3
• Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.RecruitingNCT05048069
• The "Global Paradise System" RegistryRecruitingNCT05027685
• AB122 Platform StudyRecruitingNCT04999761Phase 1
• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic ImpairmentRecruitingNCT04953910Phase 1
• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal ImpairmentRecruitingNCT04953897Phase 1
• A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)RecruitingNCT04782258Phase 3
• Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene AbnormalitiesRecruitingNCT04683250Phase 1/2
• A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic SyndromeRecruitingNCT04608110Phase 1
• A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)RecruitingNCT04256317Phase 2/3
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)Enrolling by invitationNCT04093570Phase 2
• A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar DepressionRecruitingNCT03423680Phase 3
• A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and WomenCompletedNCT07542847Phase 1Results posted
• A Trial to Assess a Wearable Patch's Functioning to Detect Medication IngestionCompletedNCT06372210Not applicableResults posted
• A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult ParticipantsCompletedNCT06212804Phase 1Results posted
• Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With SchizophreniaCompletedNCT06036108Phase 1Results posted
• A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)TerminatedNCT05835011Phase 2Results posted
• A Study of TAS3351 in NSCLC Patients With EGFRmtTerminatedNCT05765734Phase 1Results posted
• A Study to Assess the Use of Methylone in the Treatment of PTSDCompletedNCT05741710Phase 1/2Results posted
• An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic MedicationCompletedNCT05741528Phase 3Results posted
• A Long-term Trial of ETC-1002 in Patients With Hyper-LDL CholesterolemiaCompletedNCT05687071Phase 3Results posted
• A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL CholesterolemiaCompletedNCT05683340Phase 3Results posted
• A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic MedicationCompletedNCT05628103Phase 3Results posted
• A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])CompletedNCT05615363Phase 2Results posted
• A Long-term Trial of OPA-15406 in Infants With Atopic DermatitisCompletedNCT05372653Phase 3Results posted
• Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TBCompletedNCT05221502Phase 2Results posted
• A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating DisorderCompletedNCT05113953Phase 2Results posted
• Efficacy of Centanafadine SR as a Potential Smoking Cessation TreatmentCompletedNCT05066724Phase 2Results posted
• Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive DisorderCompletedNCT04830215Phase 4Results posted
• A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With HypercholesterolemiaCompletedNCT04784442Phase 2Results posted
• Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive DisorderCompletedNCT04770285Not applicableResults posted
• Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer PatientsCompletedNCT04737187Phase 3Results posted
• Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial CarcinomaTerminatedNCT04601857Phase 2Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedNCT04464564Phase 3Results posted
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedNCT04408755Phase 3Results posted
• A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell LymphomaTerminatedNCT04362007Phase 1/2Results posted
• A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine PatientsCompletedNCT04355117Phase 3Results posted
• Safety and Efficacy Study of VIS649 for IgA NephropathyCompletedNCT04287985Phase 2Results posted
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148CompletedNCT04258839Phase 3Results posted
• A Phase 2 Trial of OPC-64005 for Major Depressive DisorderCompletedNCT04244253Phase 2Results posted
• Futibatinib in Patients With Specific FGFR AberrationsTerminatedNCT04189445Phase 2Results posted
• Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)CompletedNCT04186403Phase 2/3Results posted
• A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese SubjectsCompletedNCT04182958Phase 1Results posted
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum DisorderCompletedNCT04174365Phase 3Results posted
• Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress DisorderCompletedNCT04174170Phase 3Results posted
• Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSDCompletedNCT04124614Phase 3Results posted
• A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral DosesCompletedNCT04118127Phase 1Results posted
• A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.CompletedNCT04115319Phase 3Results posted
• A Trial of Brexpiprazole in the Treatment of Borderline Personality DisorderCompletedNCT04100096Phase 2Results posted
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene RearrangementsTerminatedNCT04093362Phase 3Results posted
• A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With SchizophreniaCompletedNCT04092686Phase 3Results posted
• Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)CompletedNCT04081363Phase 2Results posted
• A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With SchizophreniaCompletedNCT04072354Phase 3Results posted
• A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) ImagingCompletedNCT04038957Phase 1Results posted

← Otsuka Holdings Co., Ltd. overview and focus areas